CIK 0001080014
- Large accelerated filer
Innoviva, Inc.
Sign in to watch- Ticker
- INVA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943265960
- Phone
- +1 650-238-9600
- Business address
- 1350 OLD BAYSHORE HIGHWAY, SUITE 400, BURLINGAME, CA, 94010
- Former names
- THERAVANCE INC, ADVANCED MEDICINE INC
- 4 Grant or award Director acquired 10,517 shares (grant or award)
- 4 Grant or award Director acquired 10,517 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 14,513 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 14,513 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale President & Chief Exec Officer sold 12,022 shares at $13.13 ($157,791)
- 4 Open-market sale Sr. VP & Chief Scientific Off. sold 13,000 shares at $13.29 ($172,795)
- 4 Open-market sale Sr. VP & Chief Comm. Officer sold 5,215 shares at $13.26 ($69,145)
- 4 Open-market sale SVP and CFO sold 15,285 shares at an average $13.28 ($202,969)
- 4 Shares withheld for taxes President & Chief Exec Officer gave up 43,038 shares (to pay taxes)
- 4 Shares withheld for taxes Sr VP & Chief Business Officer gave up 4,470 shares (to pay taxes)
- 4 Shares withheld for taxes Sr. VP & Chief Comm. Officer gave up 2,886 shares (to pay taxes)
- 4 Shares withheld for taxes President & Chief Exec Officer gave up 12,917 shares (to pay taxes)
- 4 Open-market sale SVP and CFO sold 1,825 shares at $12.20 ($22,265)
- 4 Shares withheld for taxes Sr VP & Chief Business Officer gave up 3,179 shares (to pay taxes)
- 4 Shares withheld for taxes Sr. VP & Chief Scientific Off. gave up 2,596 shares (to pay taxes)
Page 10 of 39 · 776 filings